Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs)

Triple Negative Breast Cancer (TNBC) is defined by the lack of ERα, PR expression and HER2 overexpression and is the breast cancer subtype with the poorest clinical outcomes. Our aim was to identify genes driving TNBC proliferation and/or survival which could represent novel therapeutic targets. We...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Orr, Katy, Buckley, Niamh E., Haddock, Paula, James, Colin, Parent, Jean-Luc, McQuaid, Stephen, Mullan, Paul B.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342429/
https://ncbi.nlm.nih.gov/pubmed/27487152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10969
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki